Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities

BACKGROUND: Glioblastoma is the deadliest and most prevalent brain tumor. Dexamethasone (DXM) is a commonly used steroid for treating glioblastoma patients for alleviation of vasogenic edema and pain prior to treatment with chemotherapeutic drugs. Temozolomide (TMZ), an alkylating agent, has recentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Arabinda, Banik, Naren L, Patel, Sunil J, Ray, Swapan K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544397/
https://www.ncbi.nlm.nih.gov/pubmed/15588281
http://dx.doi.org/10.1186/1476-4598-3-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544397/
https://www.ncbi.nlm.nih.gov/pubmed/15588281
http://dx.doi.org/10.1186/1476-4598-3-36

Ejemplares similares